Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium for Psychosis and Agitation in Alzheimer's Disease
NCT02129348Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jun 2014
- Primary completion
- Jan 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium in Alzheimer's disease (AD), sponsored by New York State Psychiatric Institute. Started Jun 2014; status: completed.
02
Drugs
lithium
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02129348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02129348.